Citations

Clear

4847 citation(s) found for "Yu, Eric".

Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancer
Routman, David M. , Day, Courtney N. , Harmsen, William S. , Haller, Travis J. , Moore, Eric J. , Foote, Robert L. , Neben-Wittich, M.A. , Price, Katharine A. , Abel, Kathryn M. Van , Haller, Travis, Moore, Eric J , Neben-Wittich, Michelle, Van Abel, Kathryn M , Routman, David M , Yin, Linda X. , Bartemes, Kathleen R. , Price, Daniel L. , Chintakuntlawar, Ashish V. , Daniel, J.

Mayo Clinic

Head & Neck | September 21, 2022 | Volume: 44 | Issue: 12 | Pages: 2760-2768

10.1002/hed.27198 | PMID 36129387 Get It

AbstractBackgroundWe aim to explore the prognostic role of absolute lymphocyte count (ALC) before, during, and after treatment on oncologic outcomes in human papillomavirus associated oropharyngeal cancer (HPV(+)OPSCC).MethodsRetrospective cohort at a tertiary center, 2006–2018. Multivariable Cox regressions were used to determine the effect of ALC on risk of progression. Univariate linear regression was performed to determine clinical factors associated with lower ALC.ResultsAll 197 patients underwent primary surgery. Mean (SD) ALC nadirs (×109 cells/L) were: baseline (N = 149): 1.69 (0.56); postoperative (N = 126): 1.58 (0.59); post‐RT (N = 141): 0.68 (0.35) and long‐term (N = 105): 0.88 (0.37). Lower baseline ALC nadir was associated with worse overall survival (HR 3.85, 95%CI: 1.03–14.29, p = 0.04). Lower postoperative ALC nadir was associated with higher risk of progression (HR 2.63, 95%CI: 1.04–6.67, p = 0.04).ConclusionsLower baseline ALC is associated with worse survival, whereas lower postoperative ALC is associated with increased risk of progression in surgically treated HPV(+)OPSCC.Level of Evidence3
P18 Pemigatinib for previously treated locally advanced or metastatic cholangiocarcinoma: final results from FIGHT-202
Sahai, Vaibhav , Vaccaro, Gina M. , Rajabi, Raed MAl, Paulson, Andrew Scott , Gallinson, David, Oh, Do‐Youn , Catenacci, Daniel V.T. , Lihou, Christine , Véronèse, L., Sahai, Vaibhav , Vogel, Arndt , Hollebecque, Antoine , Melisi, Davide , Borad, Mitesh J. , Murphy, Adrian , Dotan, Efrat , Cutsem, Eric Van , Zhen, Huiling, Abou‐Alfa, Ghassan K.

Mayo Clinic

Abstracts | September 20, 2022 | Volume: No volume available | Issue: No issue available | Pages: A44.1-A44

10.1136/gutjnl-2022-basl.69 Get It

P09 Long-term obeticholic acid (OCA) for Primary Biliary Cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the GLOBAL PBC real-world database
Perez, Carla , Adekunle, Femi, Mayne, Tracy J. , Malecha, Elizabeth Smoot, Ness, Eric , Meer, Adriaan J Van Der, Nevens, Frederik , Bruns, Tony , Floreani, Annarosa , Mayo, Marlyn J. , Thorburn, Douglas , Gulamhusein, Aliya , Bowlus, Christopher L. , Lindor, Keith D. , Bruns, Tony , Bowlus, Christopher L , Meer, Adriaan van der , Lammers, Willem J. , Trivedi, Palak Jitendrakumar , Battezzati, Pier Maria , Kowdley, Kris V. , Cazzagon, Nora , Mason, Andrew L. , Parés, Albert , Londoño, Maria, Invernizzi, Pietro , Carbone, Marco , Lleò, Ana , Dalekos, George Ν. , Gatselis, Nikolaos , Verhelst, Xavier , Janssen, Harry L.A. , Trauner, Michael , Corpechot, Christophe , Hirschfield, Gideon M. , Hansen, Bettina E.

Mayo Clinic

Abstracts | September 20, 2022 | Volume: No volume available | Issue: No issue available | Pages: A37-A37

10.1136/gutjnl-2022-basl.60 Get It

Differentiation of hydrochlorothiazide-induced dermatitis from stasis dermatitis
Abdelwahab, Rewan , Tangalos, Eric G., Matulis, John C. , Matulis, John

Mayo Clinic

BMJ Case Reports | September 20, 2022 | Volume: 15 | Issue: 9 | Pages: e249884

10.1136/bcr-2022-249884 | PMID 36127034 Get It

A woman in her 60s with a history of hypertension and stasis dermatitis presented to a primary care clinic with a bilateral, erythematous rash on the legs, stomach, and chest. Photosensitive rash and dermatitis may be caused by many conditions. Hydrochlorothiazide-induced dermatitis is a rare side effect of thiazide diuretics. Early identification of sulfa-sensitivity and photoallergic or phototoxic reaction is essential to accurate diagnosis and treatment of photosensitive dermatitis. Soliciting a targeted history is essential to delineating drug-induced dermatitis from stasis dermatitis. A thorough skin examination can elucidate the focal or extensive nature of the rash and is essential to making an accurate diagnosis. Immediate cessation of hydrochlorothiazide and switching drugs classes for hypertension management typically leads to resolution of symptoms.
The 50 Most Cited Publications on Concentrated Bone Marrow Aspirate with Application in Orthopaedic Surgery
Oeding, Jacob F. , Hernandez, Hunter , Bi, Andrew S. , Kennedy, John G. , Jazrawi, Laith M. , Oeding, Jacob F , Strauss, Eric J. , Campbell, Kirk A.

Mayo Clinic

The Journal of Knee Surgery | September 19, 2022 | Volume: 36 | Issue: 14 | Pages: 1467-1472

10.1055/a-1946-6981 | PMID 36122693 Get It

AbstractConcentrated bone marrow aspirate (cBMA) has garnered widespread and increasing attention in recent years. We aimed to characterize the most influential articles in cBMA research while clarifying controversies surrounding its use and clinical efficacy and identifying important areas on which to focus future research efforts. The Science Citation Index Expanded subsection of the Web of Science Core Collection was systematically searched to identify the top 50 most cited publications on orthopaedic cBMA research. Publication and study characteristics were extracted, and Spearman's correlations were calculated to assess the relationship between citation data and level of evidence. The top 50 articles were published between the years 1996 and 2018, with 58% published in the year 2010 or later. Of the 29 studies for which level of evidence was assessed, the majority were Level IV (24, 83%). Twenty-one articles (42%) were classified as basic science or translational (9 cell culture, 8 animal study, and 4 using human blood samples). Application to treat cartilage defects was the most common focus of studies (17 studies, 34%), followed by analysis of cBMA composition (14 studies, 28%). No correlation was found between rank, citation rate, or year of publication and level of evidence. The most influential articles on cBMA are recent and consist of a majority low level of evidence studies. Cohort studies were the most common study type among the top 50 most cited articles, while basic science articles were relatively less common. These results suggest a rapidly evolving field with the potential to better explain inconsistent clinical results with improved understanding and documentation of basic science concepts in addition to large-scale, prospective clinical trials. Orthobiologics especially cBMA holds great promise for the future, and higher level clinical trials will help better define the best clinical uses for this treatment.
MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies
Inguanzo, Anna , Przybelski, Scott A. , Diaz‐Galvan, Patricia , Lowe, Val J. , Boeve, Bradley F. , Beek, Marleen van de , Blanc‬, ‪Frederic, Sousa, Paulo Loureiro de , Philippi, Nathalie , Demuynck, Catherine, Nedelská, Zuzana , Oppedal, Ketil , Westman, Eric , Boeve, Brad , Nedelska, Zuzana , Westman, Eric , Inguanzo, Anna , Diaz-Galvan, Patricia , Ferreira, Daniel , Poulakis, Konstantinos , Mohanty, Rosaleena , Schwarz, Christopher G. , Lemstra, Afina W. , Flier, Wiesje M. van der , Barkhof, Frederik , Cretin, Benjamin , Hort, Jakub , Segura, Bàrbara , Junqué, Carme , Aarsland, Dag , Kantarci, Kejal

Mayo Clinic

No container title available | September 19, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2015284/v1 Get It

Abstract Background. Dementia with Lewy bodies (DLB) is a neurodegenerative disorder with a wide heterogeneity of symptoms, which suggests the existence of different subtypes. Objectives. We used data-driven analysis of MRI data to investigate DLB subtypes. Methods. We included 165 probable DLB from the Mayo Clinic and 3 centers from the European DLB consortium and performed a hierarchical cluster analysis to identify subtypes based on gray matter (GM) volumes. To characterize the subtypes, we used demographic and clinical data, as well as β-amyloid and cerebrovascular biomarkers at baseline, and cognitive decline over three years. Results. We identified 3 subtypes: an older subtype with reduced cortical GM volumes, worse cognition, and faster cognitive decline (n=49, 30%); a subtype with low GM volumes in fronto-occipital regions (n=76, 46%); and a subtype of younger patients with the highest cortical GM volumes, proportionally lower GM volumes in basal ganglia and the highest frequency of cognitive fluctuations (n=40, 24%). Conclusions. This study shows the existence of MRI subtypes in DLB, which may have implications for clinical workout, research, and therapeutic decisions.
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
Mao, Jun J. , Ismaila, Nofisat , Bao, Ting , Barton, Debra L. , Ben‐Arye, Eran , Garland, Eric L. , Greenlee, Heather , LeBlanc, Thomas W. , Lee, Richard T. , López, Ana María , Loprinzi, Charles L. , MacLeod, Jodi , Master, Viraj A. , Ramchandran, Kavitha , Walker, Eleanor , Witt, Claudia M. , Barton, Debra , Leblanc, Thomas , Loprinzi, Charles , Lyman, Gary H , MacLeod, Jodi , Wagner, Lynne , Bruner, Deborah , Witt, Claudia M , Bruera, Eduardo , Mao, Jun J , Ramchandran, Kavitha J , Wagner, Lynne I. , Bruner, Deborah Watkins

Mayo Clinic

Journal of Clinical Oncology | September 19, 2022 | Volume: 40 | Issue: 34 | Pages: 3998-4024

10.1200/jco.22.01357 | PMID 36122322 Get It

PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other health care providers on integrative approaches to managing pain in patients with cancer. METHODS The Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included pain intensity, symptom relief, and adverse events. Expert panel members used this evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS The literature search identified 227 relevant studies to inform the evidence base for this guideline. RECOMMENDATIONS Among adult patients, acupuncture should be recommended for aromatase inhibitor–related joint pain. Acupuncture or reflexology or acupressure may be recommended for general cancer pain or musculoskeletal pain. Hypnosis may be recommended to patients who experience procedural pain. Massage may be recommended to patients experiencing pain during palliative or hospice care. These recommendations are based on an intermediate level of evidence, benefit outweighing risk, and with moderate strength of recommendation. The quality of evidence for other mind-body interventions or natural products for pain is either low or inconclusive. There is insufficient or inconclusive evidence to make recommendations for pediatric patients. More research is needed to better characterize the role of integrative medicine interventions in the care of patients with cancer. Additional information is available at https://integrativeonc.org/practice-guidelines/guidelines and www.asco.org/survivorship-guidelines .
Adolf Kussmaul (1822–1902), and the naming of “poliomyelitis”
Toodayan, Nadeem , Matteson, Eric L. , Matteson, Eric

Mayo Clinic

Journal of the History of the Neurosciences | September 16, 2022 | Volume: 31 | Issue: 4 | Pages: 601-624

10.1080/0964704x.2022.2112534 | PMID 36112840 Get It

Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patie
Lehrer, Eric J. , Ahluwalia, Manmeet S. , Gurewitz, Jason , Bernstein, Kenneth , Niranjan, Ajay , Wei, Zhishuo , Lunsford, L. Dade , Fakhoury, Kareem , Rusthoven, Chad G. , Mathieu, David , Trudel, Claire, Malouff, Timothy D. , Bonney, Phillip A. , Hwang, Lindsay , Zada, Gabriel , Patel, Samir , Deibert, Christopher P., Franzini, Andrea , Attuati, Luca , Prasad, Rahul N. , Raval, Raju R. , Lee, Cheng‐Chia , Green, Sheryl , Sheehan, Jason P. , Mathieu, David , Ahluwalia, Manmeet S , Kondziolka, Douglas , Ruiz-García, Henry , Yu, Cheng‐Ping , Picozzi, Piero , Palmer, Joshua D. , Yang, Huai‐Che , Jones, Brianna M. , Trifiletti, Daniel M.

Mayo Clinic

Journal of Neurosurgery | September 16, 2022 | Volume: 138 | Issue: 5 | Pages: 1178-1187

10.3171/2022.7.jns22752 | PMID 36115055 Get It

OBJECTIVE Immune checkpoint inhibitors (ICIs) and stereotactic radiosurgery (SRS) are commonly utilized in the management of brain metastases. Treatment-related imaging changes (TRICs) are a frequently observed clinical manifestation and are commonly classified as imaging-defined radiation necrosis. However, these findings are not well characterized and may predict a response to SRS and ICIs. The objective of this study was to investigate predictors of TRICs and their impact on patient survival. METHODS This retrospective multicenter cohort study was conducted through the International Radiosurgery Research Foundation. Member institutions submitted de-identified clinical and dosimetric data for patients with non–small cell lung cancer (NSCLC), melanoma, and renal cell carcinoma (RCC) brain metastases that had been treated with SRS and ICIs. Data were collected from March 2020 to February 2021. Univariable and multivariable Cox and logistic regression analyses were performed. The Kaplan-Meier method was used to evaluate overall survival (OS). The diagnosis-specific graded prognostic assessment was used to guide variable selection. TRICs were determined on the basis of MRI, PET/CT, or MR spectroscopy, and consensus by local clinical providers was required. RESULTS The analysis included 697 patients with 4536 brain metastases across 11 international institutions in 4 countries. The median follow-up after SRS was 13.6 months. The median age was 66 years (IQR 58–73 years), 54.1% of patients were male, and 57.3%, 36.3%, and 6.4% of tumors were NSCLC, melanoma, and RCC, respectively. All patients had undergone single-fraction radiosurgery to a median margin dose of 20 Gy (IQR 18–20 Gy). TRICs were observed in 9.8% of patients. The median OS for all patients was 24.5 months. On univariable analysis, Karnofsky Performance Status (KPS; HR 0.98, p < 0.001), TRICs (HR 0.67, p = 0.03), female sex (HR 0.67, p < 0.001), and prior resection (HR 0.60, p = 0.03) were associated with improved OS. On multivariable analysis, KPS (HR 0.98, p < 0.001) and TRICs (HR 0.66, p = 0.03) were associated with improved OS. A brain volume receiving ≥ 12 Gy of radiation (V12Gy) ≥ 10 cm3 (OR 2.78, p < 0.001), prior whole-brain radiation therapy (OR 3.46, p = 0.006), and RCC histology (OR 3.10, p = 0.01) were associated with an increased probability of developing TRICs. The median OS rates in patients with and without TRICs were 29.0 and 23.1 months, respectively (p = 0.03, log-rank test). CONCLUSIONS TRICs following ICI and SRS were associated with a median OS benefit of approximately 6 months in this retrospective multicenter study. Further prospective study and additional stratification are needed to validate these findings and further elucidate the role and etiology of this common clinical scenario.
Impact of race-independent equations on estimating glomerular filtration rate for the assessment of kidney dysfunction in liver disease
Stämmler, Frank , Derain‐Dubourg, Laurence, Meeusen, Jeffrey W. , Dasari, Surendra , Robertson, Andrew, Schiffer, Eric, Dubourg, Laurence , Lemoine, Sandrine , Lieske, John C.

Mayo Clinic

No container title available | September 15, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2044973/v1 Get It

Abstract Background: Altered hemodynamics in liver disease often results in overestimation of glomerular filtration rate (GFR) by creatinine-based GFR estimating (eGFR) equations. Recently, we have validated a novel eGFR equation based on serum myo-inositol, valine, and creatinine quantified by nuclear magnetic resonance spectroscopy in combination with cystatin C, age and sex (GFRNMR). We hypothesized that GFRNMRcould improve chronic kidney disease (CKD) classification in the setting of liver disease. Results: We conducted a retrospective multicenter study in 205 patients with chronic liver disease (CLD), comparing the performance of GFRNMRto that of validated CKD-EPI eGFR equations, including eGFRcr (based on creatinine) and eGFRcr-cys (based on both creatinine and cystatin C), using measured GFR as reference standard. GFRNMR outperformed all other equations with a low overall median bias (-1 vs. -6 to 4 ml/min/1.73 m2 for the other equations; p < 0.05) and the lowest difference in bias between reduced and preserved liver function (-3 vs. -16 to -8 ml/min/1.73 m2for other equations). Concordant classification by CKD stage was highest for GFRNMR (59% vs. 48% to 53%) and less biased in estimating CKD severity compared to the other equations. GFRNMR P30 accuracy (83%) was higher than that of eGFRcr (75%; p = 0.019) and comparable to that of eGFRcr-cys (86%; p = 0.578). Conclusions: Addition of myo-inositol and valine to creatinine and cystatin C in GFRNMR further improved GFR estimation in CLD patients and accurately stratified liver disease patients into CKD stages.